This inventor holds 2 USPTO granted patents. Top assignee: Uti Limited Partnership. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Erin Laurel Stephenson: Innovator in Neurological Treatments
Introduction
Erin Laurel Stephenson is a prominent inventor based in Calgary, Canada. She has made significant contributions to the field of neurological treatments through her innovative research and development. With a total of 2 patents, her work focuses on advancing medical solutions for various neurological diseases.
Latest Patents
Erin's latest patents include groundbreaking research on fluorinated N-acetyl glucosamine analogs and xylose derivatives. These patents relate to analogs of N-acetyl glucosamine that are fluorinated at the 4- and/or 6-positions, as well as derivatives of xylose at the anomeric position. The applications of these innovations are aimed at treating neurological diseases such as multiple sclerosis, inflammation, cancer, and central nervous system injuries.
Career Highlights
Erin is currently associated with Uti Limited Partnership, where she continues to push the boundaries of medical research. Her work is characterized by a commitment to improving treatment options for patients suffering from complex neurological conditions.
Collaborations
Throughout her career, Erin has collaborated with notable professionals in her field, including Khalil Sherali Rawji and Michael Bradley Keough. These partnerships have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Erin Laurel Stephenson stands out as a dedicated inventor whose work is making a significant impact in the realm of neurological treatments. Her innovative patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.